Completed PHASE4 INTERVENTIONAL 3-arm NCT00418067

Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions (ZEST)

Comparison of the Efficacy and the Safety of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions

Sponsor: Medtronic Vascular

Conditions Coronary Artery Disease

Interventions Cypher Endeavor Taxus Liberte

Updated 6 times since 2017 Last updated: Aug 20, 2012 Started: Oct 31, 2006 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00418067, this PHASE4 trial focuses on Coronary Artery Disease and remains completed. Sponsored by Medtronic Vascular, it has been updated 6 times since 2006, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Vascular
Seung-Jung Park

Data source: CardioVascular Research Foundation, Korea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bucheon-si, South Korea , Daegu, South Korea , Daejeon, South Korea , Gangneung, South Korea , Gwangju, South Korea , Ilsan, South Korea , Jeonju, South Korea , Pusan, South Korea , Pyeongchon, South Korea , Seongnam, South Korea and 4 more locations